Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on
top health stories.
Denmark bans bestiality in move against animal sex tourism
21 Apr 2015 at 9:50am
Denmark passed legislation on Tuesday banning bestiality, toughening a law that animal rights activists feared was encouraging animal sex tourists to visit the country. The bill amends a previous ban on intercourse that harms animals, something Farm Minister Dan Jorgensen argued was difficult to prove. Those voting for the bill said Denmark did not want to remain the last northern European country where bestiality was legal, as this was attracting animal sex tourists. "There are frequent reports of the occurrence of organized animal sex shows, clubs and animal brothels in Denmark," the Danish Ethical Council for Animals, an independent advisory board under the food and agriculture ministry, said in a report, while adding that it had not been able to verify the reports.
Q&A: What is listeria? Bacteria found in Blue Bell ice cream
21 Apr 2015 at 9:49am
WASHINGTON (AP) ? Blue Bell Creameries is pulling all of its products off the shelves after samples of its ice cream tested positive for a potentially deadly bacteria ? listeria.
Meat as a Seasoning
21 Apr 2015 at 9:43am
The South has a long tradition of using cheap cuts of meat often cured and smoked to season dishes. A couple of ham hocks will flavor a big pot of beans, smoked turkey butts make collard greens a wonderful dish. With all the talk about a vegan diet being the best, carnivores are rebelling. They are clinging to meat with a white hot passion....
Chamomile tea tied to lower thyroid cancer risk
21 Apr 2015 at 9:34am
By Lisa Rapaport (Reuters Health) - Consumption of chamomile tea was linked with a lower risk of thyroid cancer in a small Greek study. Researchers interviewed some Athens residents about their lifestyle, eating and drinking habits and found that people who reported drinking more chamomile tea over longer periods of time were less likely to develop thyroid malignancies or benign growths than those who didn't. While the study doesn't prove tea prevents cancer, it adds to a growing body of evidence pointing to the potential health benefits of a Mediterranean diet including lots of lean fish, fresh vegetables and healthy fats in addition to tea, study co-author Dr. Athena Linos, an environmental health researcher at Prolepsis in Greece, said by email. "The finding was not surprising to me because many aspects of the Mediterranean diet have been shown to be protective towards cancer in general," Linos said.
Hormel Foods, other meat company shares fall as bird flu concerns mount
21 Apr 2015 at 9:29am
By P.J. Huffstutter CHICAGO (Reuters) - The spread of a deadly strain of bird flu into an Iowa egg farm accelerated market concerns over how big of a bite the current outbreak could take from the United States' egg and poultry businesses, sending shares of several leading meat companies' down on Tuesday. Hormel Foods Corp shares were down more than 3 percent in early afternoon trading after the Minnesota-based company said the impact of the virulent strain of avian influenza may drag its fiscal 2015 earnings toward the lower end of forecasts. Minnesota, the largest turkey-producing state in the country, has been the hardest hit so far, followed by farms in Arkansas, Missouri, the Dakotas, Wisconsin and Iowa. Hormel Chief Executive Officer Jeffrey M. Ettinger said in a statement on Monday the company was seeing "significant challenges" to its turkey supply chain because of the highly pathogenic avian influenza outbreaks in Wisconsin and Minnesota, where its Hormel and Jennie-O Turkey Store units are based.
MMR vaccine not linked to autism, even in high-risk kids
21 Apr 2015 at 9:17am
By Andrew M. Seaman (Reuters Health) - The measles, mumps and rubella (MMR) vaccine is not linked to development of autism spectrum disorders, even among children considered to be at risk, a large new study finds. Among nearly 100,000 children, receipt of the MMR vaccine did not increase the risk for autism spectrum disorder (ASD), regardless of whether kids were at higher risk because an older sibling already had the condition, researchers write in JAMA. "We don?t know what does unfortunately, but it?s not the MMR vaccine." The results should be reassuring, she said. Autism spectrum disorder is a range of symptoms that often includes difficulties with communication and social interaction, according to the U.S. National Institute of Mental Health.
Attention Walmart Shoppers: Don't Look for Health Care Answers Here
21 Apr 2015 at 8:55am
Recently, there have been an increasing number of articles asking why healthcare can't be more like other industries. Authors question why health care doesn't emulate the automation in manufacturing, the safety improvements in aerospace, or the declining price points in computer sales. This columnist is also part of the media chorus on the...
Low-cost gene testing for breast cancer enters market
21 Apr 2015 at 8:38am
California-based startup Color Genomics announced on Tuesday genetic testing for breast and ovarian cancers for a fraction of the current cost. The fee also includes a consultation with a board-certified genetic counselor from Color, who can also share the results with a healthcare provider, if desired, according to the company's website.
Teva Pharmaceutical offers to buy Mylan for $40.1 bn
21 Apr 2015 at 8:33am
Israel's Teva Pharmaceutical Tuesday launched an unsolicited bid to buy Mylan for $40.1 billion in a transaction that would create a behemoth in generic drugs. Teva's cash-and-stock bid would quash an unsolicited bid by Mylan earlier this month to acquire Perrigo for $28.9 billion. Teva said its bid amounted to superior value for Mylan shareholders compared with Mylan's approach to Perrigo. Under the offer, Mylan shareholders would receive a premium of 37.7 percent compared with the Mylan stock price of $59.57 prior to its April 8 bid for Perrigo, Teva said.
'Skinny Mom' Sarah Stage Debuts Insanely Toned Abs a Week After Giving Birth
21 Apr 2015 at 8:24am
Instagram sensation Sarah Stage is already back in shape less than a week after giving birth.
Another study finds no link between vaccine, autism
21 Apr 2015 at 8:24am
Yet another scientific study has found no link between autism and the vaccine against measles, mumps and rubella (MMR), according to US research published on Tuesday. The findings in the Journal of the American Medical Association (JAMA) are based on a study of about 95,000 children with older siblings, some of whom had autism spectrum disorder (ASD). "Consistent with studies in other populations, we observed no association between MMR vaccination and increased ASD risk among privately insured children," said the study, led by Anjali Jain, a doctor in Falls Church, Virginia.
New U.S. mammogram guidelines stick with screening from age 50
21 Apr 2015 at 8:23am
By Julie Steenhuysen CHICAGO (Reuters) - New mammogram screening guidelines from an influential panel of U.S. experts reaffirm earlier guidance that breast cancer screening should begin at age 50 for most women, but they acknowledge that women in their 40s also benefit, something experts say is a step in the right direction. "They made it really clear this time around, unlike 2009, that the discussion between a woman and a clinician about breast cancer screening should begin at 40," said Dr. Richard Wender, chief cancer control officer at the American Cancer Society. The Department of Health and Human Services provided for mammogram coverage for women age 40 to 49 after the health panel made its recommendation in 2009. The department said on Monday that the guidelines are only in draft form and that nothing has changed regarding access to mammograms or other preventive services.
Texas ice cream maker recalls all products over Listeria
21 Apr 2015 at 8:04am
By Marice Richter DALLAS (Reuters) - Texas-based Blue Bell Creameries announced on Monday a voluntary recall of all its ice cream and frozen treat products from store shelves due to continuing problems with the Listeria bacteria. The move is the most recent in a string of recall announcements by the 108-year-old company, based in Brenham, after health officials said last month three people made ill by Listeria between January 2014 and January 2015 had died in a Kansas hospital where Blue Bell frozen treats were served. Monday's decision came after the bacteria was detected in Chocolate Chip Cookie Dough ice cream samples that were tested last month. "We are heartbroken about this situation and apologize to all of our loyal Blue Bell fans and customers," Blue Bell CEO Paul Kruse said.
Indian parliamentary committee recommends price caps for all drugs
21 Apr 2015 at 7:59am
An Indian parliamentary committee has recommended that price caps should be extended to all drugs in the country and that the government should expedite the capping process. Indian law allows the National Pharmaceutical Pricing Authority (NPPA) regulator to fix prices of drugs on a list of essential medicines, thereby keeping prices in check in a country where a majority of people live on less than $2 a day and health insurance is scarce. "The committee recommend that the scope of price control needs to be enlarged to make all the drugs available, especially life saving drugs in all parts of the country," the committee's report said. Reuters reported this month that all the drugs on the government's HIV/AIDS and tuberculosis control programs are likely to be added to the list of drugs subject to price caps.
Generic drugmaker Teva makes $40 billion offer for rival Mylan
21 Apr 2015 at 7:56am
Generic drugmaker Teva Pharmaceutical Industries Ltd. on Tuesday proposed buying Mylan for $40 billion, saying it was a better deal than the smaller rival's offer to buy Perrigo Co. The bid comes after weeks of speculation that Teva, the world's largest generic company, would make a bid for Mylan. Teva said the stock-and-cash offer of $82 a share represented a 48 percent premium to Mylan's stock price on March 10, which it said was the last day of trading prior to the widespread speculation. Shares of Mylan were up 8.4 percent at $73.76 in morning Nasdaq trading, while Teva rose 1.7 percent to $64.34 on the New York Stock Exchange. Perrigo fell 1.8 percent to $194.77.